This study tested the hypothesis that an integrated biomarker calculated from a combination of plasma vitamin C , cholesterol-adjusted carotenoid concentration and Ferric Reducing Antioxidant Power ( FRAP ) had more power to predict F&V intake than each individual biomarker .